EP Patent

EP3785717A1 — Methods for treating coronaviridae infections

Assigned to Gilead Sciences Inc · Expires 2021-03-03 · 5y expired

What this patent protects

Provided is a compound having the formula:or a pharmaceutically acceptable salt thereof for use in a method of treating a Coronaviridae infection in a human in need thereof.

USPTO Abstract

Provided is a compound having the formula:or a pharmaceutically acceptable salt thereof for use in a method of treating a Coronaviridae infection in a human in need thereof.

Drugs covered by this patent

Patent Metadata

Patent number
EP3785717A1
Jurisdiction
EP
Classification
—
Expires
2021-03-03
Drug substance claim
No
Drug product claim
No
Assignee
Gilead Sciences Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.